Principal Investigator / Senior Research Scientist – Cancer Genomics
125 Lide Road
Beitou District, Taipei City 11259
Imagine pioneering the next frontier in cancer genomic profiling from Taiwan, one of the world's technological giants. KFSYSCC beckons you to lead the charge, leveraging a 30+ year treasure trove of tissue samples unmatched by any in Asia.
As Principal Investigator/Senior Research Scientist, you will be immersed in an environment that values scientific rigor, innovation, and resourcefulness. Gain access to cutting-edge resources and state-of-the-art facilities. Rich not only in culture and history, Taiwan is fast becoming a hub for healthcare innovation, with a healthcare system consistently ranked among the top in the world. Enjoy a favorable cost of living, ensuring that your globally competitive salary goes further. Work among an international, English-speaking scientific community, ensuring smooth collaboration. Benefit from Taiwan's proximity to other Asian biotech centers, extending your professional influence internationally.
Powered by next generation sequencing tools, you won't just be conducting research; you will be setting global benchmarks. Seize the chance to be at the forefront of a medical revolution, making waves from the vibrant heart of Asia.
• Champion the development and application of state-of-the-art genomic profiling techniques, with an expertise in NGS platforms.
• Harness our tissue biobank to draw out valuable insights and identify research opportunities.
• Lead a multidisciplinary team of scientists, fostering collaboration, innovation, and excellence.
• Partner with clinicians to ensure the seamless integration of research findings into patient care.
• Design, initiate, and oversee groundbreaking research projects, ensuring alignment with our institution's goals and vision.
• Collaborate with global experts, research institutions, and industry partners to position our institution as a leader in cancer genomic research.
• Continuously monitor advancements in the field, integrating new techniques, tools, and methodologies as appropriate.
• Communicate research findings through publications, presentations, and other appropriate channels.
• Craft and submit research grant proposals, ensuring continued funding and support for the institution’s ambitious projects.
• Ph.D. in Molecular Biology, Genetics, Genomic Sciences, or relevant field(s).
• Completion of post-doctoral training
• Conversant in Next Generation Sequencing (NGS) and other state-of-the-art molecular and cellular tools
• A solid understanding of cancer genomics and its implications for patient care.
• Demonstrated leadership in managing scientific teams and projects.
• Exceptional analytical, organizational, and communication skills.
• A commitment to collaboration, with the ability to forge strong internal and external partnerships.
• Experience in translational research, bridging the gap between laboratory findings and clinical applications.
What We Offer:
• Unprecedented access to one of Asia's most prized tissue biobanks, a reservoir of three decades of cancer samples.
• Modern laboratory facilities equipped with the latest in genomic profiling technology.
• A supportive, innovative, and multidisciplinary work environment.
• Competitive compensation package, commensurate with experience and achievements.
• Continuous professional development opportunities.
How to Apply
To apply, please send your resume and cover letter to patrickng AT kfsyscc DOT org.
About Our Organization
The Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) stands as a beacon in the realm of cancer care, not just in Taiwan but on the global stage. As Taiwan’s first specialized cancer hospital, our legacy spans over three decades, during which we have been unwavering in our commitment to excellence. Our rich tissue biobank, cultivated meticulously over 30 years, is a testament to this dedication, offering an unparalleled wealth of research samples.
But what truly sets us apart? At KFSYSCC, our ethos is rooted in the relentless pursuit of patient-centeredness. We have not only championed innovative models like pay-for-performance reimbursement methods but also embraced multidisciplinary team-based care since our inception, underscoring our focus on quality of care. This emphasis on superior patient care outcomes, combined with our cutting-edge research capabilities, sets us apart from other cancer hospitals both in Taiwan and the United States.
We stand at the precipice of change and innovation, and as we move forward, we are seeking a visionary leader to join our trailblazing molecular medicine program. Armed with the power of our invaluable biobank and cutting-edge NGS tools, we aim to reshape the future of cancer care for our patients. Join us on this transformative journey, leveraging the past and pioneering the future as we redefine cancer care in Taiwan, backed by the legacy and reputation of Taiwan’s leading cancer center.